Changing clinical practice: management of paediatric community-acquired pneumonia

Mohamed A Elemraid1, Stephen P Rushton, Matthew F Thomas

  • 1Department of Paediatric Infectious Disease and Immunology, Newcastle upon Tyne Hospitals NHS Trust, Newcastle, UK; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.

Insights

UK pneumonia guidelines improved paediatric community-acquired pneumonia (PCAP) care. Investigations and intravenous antibiotic use decreased, with a shift towards oral antibiotics, aligning with recommendations and enhancing antimicrobial stewardship.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Practice Guidelines
  • Antimicrobial Stewardship

Background:

  • Paediatric community-acquired pneumonia (PCAP) management has evolved with guideline development.
  • Previous studies highlight variations in diagnostic and treatment approaches for PCAP.

Purpose of the Study:

  • To evaluate the impact of UK pneumonia guidelines published in 2002 on PCAP clinical features and management.
  • To compare current PCAP management with pre-guideline data from 2001-2002.

Main Methods:

  • A prospective survey of 11 hospitals in Northern England conducted in 2008-2009.
  • Data collection included clinical and laboratory findings for children (≤16 years) with pneumonia.
  • Comparison with a similar survey conducted prior to guideline implementation.

Main Results:

  • A significant reduction in investigations, including full blood count, blood cultures, and respiratory pathogen testing, was observed post-guidelines.
  • Intravenous antibiotic use decreased from 47% to 36% of total prescriptions.
  • A notable shift towards oral antibiotic monotherapy increased from 16% to 50%.

Conclusions:

  • Post-guideline changes in PCAP management, excluding routine acute phase reactant measurement, align with recommendations.
  • Improvements in antibiotic prescribing practices support antimicrobial stewardship initiatives.
  • Adoption of guidelines may offer financial benefits to healthcare services.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
58
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
88